Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
47.8M
-
Shares change
-
-3.86M
-
Total reported value, excl. options
-
$464M
-
Value change
-
-$69.4M
-
Put/Call ratio
-
0.41
-
Number of buys
-
98
-
Number of sells
-
-69
-
Price
-
$9.70
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q3 2022
198 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q3 2022.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.8M shares
of 69.1M outstanding shares and own 69.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.94M shares), BlackRock Inc. (4.62M shares), WELLINGTON MANAGEMENT GROUP LLP (2.51M shares), MILLENNIUM MANAGEMENT LLC (1.94M shares), Point72 Asset Management, L.P. (1.93M shares), GOLDMAN SACHS GROUP INC (1.88M shares), JPMORGAN CHASE & CO (1.43M shares), First Light Asset Management, LLC (1.15M shares), Balyasny Asset Management LLC (1.14M shares), and STATE STREET CORP (1.14M shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.